These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3539128)

  • 1. [Comparative in-flight study of a scopolamine-containing membrane plaster versus dimenhydrinate under defined acceleration conditions].
    Offenloch K; Zahner G; Dietlein G; Franz I
    Arzneimittelforschung; 1986 Sep; 36(9):1401-6. PubMed ID: 3539128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimotion sickness and antiemetic drugs.
    Wood CD
    Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of transdermal scopolamine and dimenhydrinate in acute vestibular disease].
    Wolf M; Kronenberg J; Leventon G
    Harefuah; 1987 Aug; 113(3-4):65-6. PubMed ID: 3500900
    [No Abstract]   [Full Text] [Related]  

  • 6. Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo.
    Klöcker N; Hanschke W; Toussaint S; Verse T
    Eur J Pharm Sci; 2001 May; 13(2):227-32. PubMed ID: 11297908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME; Royal JW; Shaw JE; Schmitt LG
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G; Goossens H; Seemann K; Souchon F; Weitz T
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1881-5. PubMed ID: 6499689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Clissold SP; Heel RC
    Drugs; 1985 Mar; 29(3):189-207. PubMed ID: 3886352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness.
    Pyykkö I; Schalén L; Jäntti V
    Acta Otolaryngol; 1985; 99(5-6):588-96. PubMed ID: 4024909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-motion sickness mechanism of ginger. A comparative study with placebo and dimenhydrinate.
    Holtmann S; Clarke AH; Scherer H; Höhn M
    Acta Otolaryngol; 1989; 108(3-4):168-74. PubMed ID: 2683568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.
    Seibel K; Schaffler K; Reitmeir P; Golly I
    Arzneimittelforschung; 2002; 52(7):529-36. PubMed ID: 12189776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Droperidol and dimenhydrinate alone or in combination for prevention of postoperative nausea and vomiting].
    Eberhart LH; Seeling W; Morin AM; Vogt N; Georgieff M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 May; 36(5):290-5. PubMed ID: 11413698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy of ginger with various antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
    Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal scopolamine in the prevention of motion sickness at sea.
    Price NM; Schmitt LG; McGuire J; Shaw JE; Trobough G
    Clin Pharmacol Ther; 1981 Mar; 29(3):414-9. PubMed ID: 7009021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action].
    Wang E
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD; Graybiel A
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progress in the therapy of motion sickness: the dimenhydrinate-containing chewing gum dragee].
    Reimann HJ; Erbel F; Bergemann B
    Ther Ggw; 1981 Dec; 120(12):1171-80. PubMed ID: 7330785
    [No Abstract]   [Full Text] [Related]  

  • 20. Transdermally administered scopolamine vs. dimenhydrinate. II. Effect on different types of nystagmus.
    Pyykkö I; Schalén L; Matsuoka I
    Acta Otolaryngol; 1985; 99(5-6):597-604. PubMed ID: 4024910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.